Clinical Trial Update: Comparison of Brivanib and Best Supportive Care (BSC) With Placebo and BSC for Treatment of Liver Cancer in Asian Patients Who Have Failed Sorafenib Treatment [Phase 3]

View source ↗

Summary

Phase 3 trial comparing brivanib plus best supportive care to placebo plus best supportive care in Asian patients with hepatocellular carcinoma who have progres…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Brivanib (brivanib)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Carcinoma, Hepatocellular | Phase 3 | Status: TERMINATED